FRASER INSTITUTE -- Quebec’s public-private pharmacare model provides more generous—and timely—access to new drugs
MONTREAL—Quebec’s universal pharmacare system,
which relies on both a public plan
and private insurance providers,
covers more drugs and provides quicker
access to new medicines than other Canadian provinces, finds
a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.
Last month, a federally-appointed advisory panel (headed by former Ontario health minister Dr. Eric Hoskins) released a report calling for a government-run taxpayer-funded national pharmacare program—vastly different from Quebec’s system.
“The Quebec model is proof that you can have universal—and generous—drug
coverage using a mix of public
and private insurance,” said Yanick Labrie, Fraser Institute senior fellow and author of Lessons from the Quebec Universal
Prescription Drug Insurance
Program.
The study finds that Quebec’s public plan provides greater access to prescription drugs
than other provincial plans in Canada.
For example, of all the drugs approved by
Health Canada from 2008 to 2017, 33.4 per cent are listed on Quebec’s public formulary
compared to 25.6 per cent in other provinces
(on average).
In fact, Quebec’s public plan covers more than 8,000 prescription drugs, while Ontario’s
Drug Benefit program covers 4,400.
Quebec also has faster
approval times for new medicines compared to other provincial plans.
Over the past 10 years, the
average wait time for new drugs (between approval by Health Canada and coverage by the public
plan) was 477 days in Quebec compared to 674 days in the other provinces.
Crucially, private
insurers active in Quebec must provide coverage that is at least equivalent
to that of the public plan, although private insurers usually provide expanded coverage to include drugs not covered
by Quebec’s public plan.
The study also notes that Quebecers have greatly benefited from
faster and easier access to
new medicines in terms of health outcomes, and although
drug costs have increased
since the program was implemented in 1997, there has been a relative decrease in the use of other health services. In fact, Quebec has a
lower level of total health
spending per capita than in
any other province in Canada.
“While not perfect,
Quebec’s mixed public-private pharmacare model proves that you don’t
need a government-run,
one-size-fits-all-provinces
system to provide universal drug coverage to patients,” Labrie said.
“With the issue of pharmacare front and centre,
it’s crucial that policymakers—and
all Canadians—are
aware of Quebec’s pharmacare program.”
READ the Executive
Summary – Click
Here
READ the Full Report – Click
Here
Comments
Post a Comment